Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
2007 StandoutScienceNobel
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors
1999 StandoutNobel
Beta-adrenoceptors in cardiac disease
1993
Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries
1991
Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism
1990
Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses
2018 StandoutNobel
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Interventions for enhancing medication adherence
2005
The pharmacogenetics of asthma: a candidate gene approach
2001
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic Receptors
1997 StandoutNobel
Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature
2000
Ulcerative colitis
2002
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
Thyroid Hormone and the Cardiovascular System
2001 Standout
GIPC Interacts with the β1-Adrenergic Receptor and Regulates β1-Adrenergic Receptor-mediated ERK Activation
2003 StandoutNobel
Effects of Thyroid Hormone on Cardiac Function - The Relative Importance of Heart Rate, Loading Conditions, and Myocardial Contractility in the Regulation of Cardiac Performance in Human Hyperthyroidism
2002
Concurrent expression of erythroid and renal aquaporin CHIP and appearance of water channel activity in perinatal rats.
1993 StandoutNobel
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
2004
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery
1999 StandoutNobel
Phosphorylation and Desensitization of the Human β1-Adrenergic Receptor
1995 StandoutNobel
β agonists: What is the evidence that their use increases the risk of asthma morbidity and mortality?
1999
Inflammatory Bowel Disease
2002 Standout
Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes.
1997 StandoutNobel
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
1991
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
The ??2-Agonist Controversy
1994
Digoxin in heart failure: Implications of recent trials
1993
The Pathophysiology and Treatment of Sepsis
2003 Standout
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Control of Myocardial Contractile Function by the Level of β-Adrenergic Receptor Kinase 1 in Gene-targeted Mice
1998 StandoutNobel
A guideline for the treatment and prevention of NSAID-induced ulcers
1998
Autonomic Control of Cardiovascular Function: Clinical Evaluation in Health and Disease
1994
Systemic side effects of topical beta‐adrenergic blockers
1996
Hypokalemic and ECG Sequelae of Combined Beta-Agonist/Diuretic Therapy
1990
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
2005 Standout
Pharmacological rate control of atrial fibrillation
2004
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Beta2 adrenergic receptors in asthma: A current perspective
1992
Airway Subsensitivity with Long-Acting ??2-Agonists Is There Cause for Concern?
1997
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Lack of Subsensitivity to Albuterol After Treatment with Salmeterol in Patients with Asthma
1999
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Alpha-Adrenergic Receptor Subtypes
1980 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
1985
Discussion
1999
Photoaffinity labeling of mammalian alpha 1-adrenergic receptors. Identification of the ligand binding subunit with a high affinity radioiodinated probe.
1984 StandoutNobel
Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor
2012 StandoutNobel
The Membrane of the Human Neonatal Red Cell
1985
The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure
1997 Standout
Polymorphism of the beta2-adrenoceptor and the response to long-term beta2-agonist therapy in asthma
1998
Functional Arteries Grown in Vitro
1999 StandoutScience
Interventions for enhancing medication adherence
2008 Standout
Radioligand Binding Studies of Adrenergic Receptors: New Insights into Molecular and Physiological Regulation
1980 StandoutNobel
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
A critical review of interventions to improve compliance with prescribed medications
1987
Abnormal Left Ventricular Function in Hyperthyroidism
1982
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.
1996 StandoutNobel
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
1996
Interventions for enhancing medication adherence
2014 Standout
Structure-based discovery of β 2 -adrenergic receptor ligands
2009 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanisms of Membrane-Receptor Regulation
1984 StandoutNobel
Cardiac Function in Mice Overexpressing the β-Adrenergic Receptor Kinase or a βARK Inhibitor
1995 StandoutScienceNobel
Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart.
1989
Differential pulse voltammetric determination of atenolol in pharmaceutical formulations and urine using nanogold modified indium tin oxide electrode
2005
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Inotropic and Sympathetic Responses to the Intracoronary Infusion of a β2-Receptor Agonist
1999
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
1983
Are There Differences Among Nonsteroidal Antiinflammatory Drugs?
1994
Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction
2000 StandoutNobel
Works of DG McDevitt being referenced
Comparison of the Effects of Prolonged Treatment with Low and High Doses of Inhaled Terbutaline on Beta-Adrenoceptor Responsiveness in Patients with Chronic Obstructive Pulmonary Disease
1990
Effects of Atenolol, Verapamil, and Xamoterol on Heart Rate and Exercise Tolerance in Digitalised Patients with Chronic Atrial Fibrillation
1989
Tachyphylaxis to Systemic But Not to Airway Responses during Prolonged Therapy with High Dose Inhaled Salbutamol in Asthmatics
1989
Beta-adrenoceptor responses to inhaled salbutamol in normal subjects
1989
A comparison of digoxin, diltiazem and their combination in the treatment of atrial fibrillation
1988
Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease.
1997
IS MAINTENANCE DIGOXIN NECESSARY IN PATIENTS WITH SINUS RHYTHM?
1979
Electrocardiographic changes induced by inhaled salbutamol after treatment with bendrofluazide: Effects of replacement therapy with potassium, magnesium and triamterene
1990
Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine.
1983
Comparative trial of atenolol and propranolol in hyperthyroidism.
1978
Studies of the effect of thyroid dysfunction on the elimination of beta‐ adrenoreceptor blocking drugs.
1977
Vagal activity is increased during intravenous isoprenaline infusion in man.
1984
Does the frequency of daily dosage influence compliance with digoxin therapy?
1981
Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2‐adrenoceptor blockade.
1989
Influence of sex‐steroid hormones on the regulation of lymphocyte beta 2‐adrenoceptors during the menstrual cycle.
1994
Sex differences in hypokalaemic and electrocardiographic effects of inhaled terbutaline.
1992
Catecholamine sensitivity in hyperthyroidism and hypothyroidism.
1978
A dose‐ranging study to evaluate the beta‐adrenoceptor selectivity of single doses of betaxolol.
1990
Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline.
1983
The assessment of beta‐adrenoceptor blocking drugs in man.
1977
Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.
1995
FURTHER OBSERVATIONS ON THE CARDIOTOXICITY OF ISOPRENALINE DURING HYPOXIA
1974
Effects of the beta 2‐adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline‐induced beta‐adrenoceptor responses in man.
1985
The effect of digoxin on 86rubidium uptake by erythrocytes from mothers and babies.
1983